Quantum BioPharma announces that Health Canada has granted a Product License for its natural health product, Qlarity. Quantum licensed a similar product, as a dietary supplement, for sale in the United States under the brand name unbuzzd. This Product License from Health Canada permits Quantum to sell Qlarity in Canada. “This is a milestone in Quantum BioPharma’s mission to bring innovative products to the market”, said Zeeshan Saeed, CEO of Quantum BioPharma. “We can now sell Qlarity to the Canadian market, leveraging its significant potential to improve consumer well-being.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma’s Licensee Unbuzzd Wellness to Host Investor Webinar on Innovative Hangover Solution
- Quantum BioPharma Receives BUY Rating from Kingswood Capital Partners
- Quantum BioPharma Announces Key Corporate Updates
- Quantum Group announces corporate updates
- Quantum BioPharma Seeks Shareholder Approval for Private Placement
